[artículo] 
inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 6 (Junio) . - pp. 751-756

Título :	Association of weight gain and metabolic syndrome in patients taking clozapine : an 8 year cohort study
Tipo de documento:	texto impreso
Autores:	Ya-Mei Bai, Autor ; Chao Cheng Lin, Autor ; Jen Yeu Chen, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 751-756
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Antipsicóticos, Índice de masa corporal, Clozapina, Síndrome metabólico, Esquizofrenia.
Resumen:	Metabolic syndrome is an important side effect associated with clozapine. It has been hypothesized that weight gain contributes to the development of metabolic syndrome, but a direct diabetogenic effect has also been suggested. We conducted an 8-year cohort study to determine the association between weight gain and metabolic parameters among schizophrenic patients taking clozapine.
Link:	./index.php?lvl=notice_display&id=28005

[artículo] Association of weight gain and metabolic syndrome in patients taking clozapine : an 8 year cohort study [texto impreso] / Ya-Mei Bai, Autor ; Chao Cheng Lin, Autor ; Jen Yeu Chen, Autor . - 2022 . - pp. 751-756.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 6 (Junio) . - pp. 751-756

Palabras clave:	Antipsicóticos, Antipsicóticos, Índice de masa corporal, Clozapina, Síndrome metabólico, Esquizofrenia.
Resumen:	Metabolic syndrome is an important side effect associated with clozapine. It has been hypothesized that weight gain contributes to the development of metabolic syndrome, but a direct diabetogenic effect has also been suggested. We conducted an 8-year cohort study to determine the association between weight gain and metabolic parameters among schizophrenic patients taking clozapine.
Link:	./index.php?lvl=notice_display&id=28005